FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Fabulous Science is Not Enough: Woodcock

[ Price : $8.95]

CDER director Janet Woodcock challenges medical researchers to change the system in ways that will help bring more drugs to more p...

Hangzhou Badi CGMP Violations

[ Price : $8.95]

FDA warns Chinas Hangzhou Badi Daily Use Chemical Company about CGMP and other violations in its manufacturing of finished drugs.

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes Enprani Co., and Hangzhou Badi Daily Use Chemical.

Public Citizen Sues FDA Seeking Cesium Chloride Ban

[ Price : $8.95]

Public Citizen 9/10 sues FDA in Washington, DC federal court over the agencys inaction to respond to the groups 7/2018 citizen pet...

FDA Develops Hepatitis A Immune Response Biomarker

[ Price : $8.95]

FDA says its scientists have developed a way to determine whether dendritic cells are primed to trigger production of antibodies a...

Ipca Laboratories FDA-483

[ Price : $8.95]

FDA releases an FDA-483 issued to Indias Ipca Laboratories with three inspection observations.

FTC Warns Makers of CBD-Infused Products

[ Price : $8.95]

The Federal Trade Commission warns three companies that they need credible and reliable scientific evidence to make health claims ...

Metrix Recalls IV Flexible Bags

[ Price : $8.95]

The Metrix Co. (Dubuque, IA) recalls several lots of its empty IV flexible containers due to the potential for leakages from the I...

Abuse, Dependence Labeling Comments

[ Price : $8.95]

Three drug companies respond to an FDA draft guidance on package insert labeling in the drug abuse and dependence section.

Improve and Pass H.R. 3: Public Citizen

[ Price : $8.95]

Public Citizen calls on the House to improve H.R. 3 to lower drug prices and then pass the legislation.